Is Amphastar Pharmaceuticals, Inc. overvalued?

Amphastar Pharmaceuticals, Inc. (AMPH) looks undervalued — trading about 38% below its fair value.

Undervalued

Price

$29.37

Fair value

$40.49

Current P/E

10.0

Normal P/E

13.8

Market cap

$1.25B

Dividend yield

0.0%

Return on equity

12.6%

Sector

Healthcare

Fair value compares AMPH's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks